Events8th International Electronic Conference on Medicinal Chemistry
Published
with-doi10.3390/ECMC2022-13230 (registering DOI)
This submission belongs to the session S4. Small molecules as drug candidates of the event 8th International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2022
Academic Editor
author-avatarMaria Emília Sousa
Citation
Joanna Fedorowicz, Laura Turzyńska, Cristina Durante-Cruz, Heidi Mäkkylä, Polina Ilina, Krzesimir Ciura, Anita Kornicka, Päivi Tammela, Jarosław Sączewski, Quaternization of fluoroquinolones – novel permanently ionized antibacterials active against biofilms, in Proceedings of 8th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2022, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2022-13230
Share
Email
Facebook
Twitter
LinkedIn

Quaternization of fluoroquinolones – novel permanently ionized antibacterials active against biofilms

Laura Turzyńska 2
Heidi Mäkkylä 3
image
1. Department of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, Poland
2. Department of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk
3. University of Helsinki
4. Department of Physical Chemistry, Faculty of Pharmacy, Medical University of Gdańsk
5. Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk
Abstract

Increasing antimicrobial resistance poses a critical problem to public health. Many strategies are engaged to combat this problem; one of them is the synthesis of hybrid drugs consisting of diverse bioactive parts merged into one molecule [1]. The risk that bacteria will mutate and evolve defense mechanisms is lower since the various pharmacophoric parts act against different molecular targets.

We developed a new class of fluoroquinolone-quaternary ammonium conjugates to obtain inhibitors of bacterial topoisomerases with membrane destabilization activity [2]. Docking studies revealed that compounds can interact with topoisomerases in the fluoroquinolone-binding mode. Hybrids were screened against Gram-positive and negative bacteria, including pathogens from the ESKAPE group and antibiotic-resistant strains, in planktonic and biofilm forms. The most effective were moderately lipophilic (CHI 10-20) cyclopropyl-substituted molecules [3]. Moreover, novel compounds exhibit negligible cytotoxicity.

The Project was financed by the Polish National Agency for Academic Exchange as a part of the Bekker Scholarship Programme.

[1] Fedorowicz, J.; Sączewski, J. Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules. Monatsh Chem 2018, 149,1199–1245. https://doi.org/10.1007/s00706-018-2215-x

[2] Fedorowicz, J.; Sączewski, J.; Konopacka, A.; Waleron, K.; Lejnowski, D.; Ciura, K.; Tomašič, T.; Skok, Ž.; Savijoki, K.; Morawska, M.; Gilbert-Girard, S.; Fallarero, A. Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents, Eur. J. Med. Chem. 2019, 179, 576-590, https://doi.org/10.1016/j.ejmech.2019.06.071

[3] Ciura, K.; Fedorowicz, J.; Kapica, H.; Adamkowska, A.; Sawicki, W.; Sączewski, J. Affinity of Fluoroquinolone–Safirinium Dye Hybrids to Phospholipids Estimated by IAM-HPLC. Processes 2020, 8, 1148. https://doi.org/10.3390/pr8091148

Keywords
antibiotics
drug research
fluoroquinolones
antibacterial agents
Poster
065845 .pdf
Development of a cowpea immature pod purée: an opportunity for the elderly to improve their autonomy in daily living activities and quality of life
Are the Co(III) complexes with diamine chelate ligands a response to new antifungal compounds?